Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan 21;8(1):e018168.
doi: 10.1136/bmjopen-2017-018168.

The Suspected CANcer (SCAN) pathway: protocol for evaluating a new standard of care for patients with non-specific symptoms of cancer

Affiliations

The Suspected CANcer (SCAN) pathway: protocol for evaluating a new standard of care for patients with non-specific symptoms of cancer

Brian D Nicholson et al. BMJ Open. .

Abstract

Introduction: Cancer survival in England lags behind most European countries, due partly to lower rates of early stage diagnosis. We report the protocol for the evaluation of a multidisciplinary diagnostic centre-based pathway for the investigation of 'low-risk but not no-risk' cancer symptoms called the Suspected CANcer (SCAN) pathway. SCAN is a new standard of care being implemented in Oxfordshire; one of a number of pathways implemented during the second wave of the Accelerate, Coordinate, Evaluate (ACE) programme, an initiative which aims to improve England's cancer survival rates through establishing effective routes to early diagnosis.

Methods and analysis: To evaluate SCAN, we are collating a prospective database of patients referred onto the pathway by their general practitioner (GP). Patients aged over 40 years, with non-specific symptoms such as weight loss or fatigue, who do not meet urgent cancer referral criteria or for whom symptom causation remains unclear after investigation via other existing pathways, can be referred to SCAN. SCAN provides rapid CT scanning, laboratory testing and clinic review within 2 weeks. We will follow all patients in the primary and secondary care record for at least 2 years. The data will be used to understand the diagnostic yield of the SCAN pathway in the short term (28 days) and the long term (2 years). Routinely collected primary and secondary care data from patients not referred to SCAN but with similar symptoms will also be used to evaluate SCAN. We will map the routes to diagnosis for patients referred to SCAN to assess cost-effectiveness. Acceptability will be evaluated using patient and GP surveys.

Ethics and dissemination: The Oxford Joint Research Office Study Classification Group has judged this to be a service evaluation and so outside of research governance. The results of this project will be disseminated by peer-reviewed publication and presentation at conferences.

Keywords: adult oncology; oncology; organisation of health services; primary care.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

    1. De Angelis R, Sant M, Coleman MP, et al. . Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study. Lancet Oncol 2014;15:23–34. 10.1016/S1470-2045(13)70546-1 - DOI - PubMed
    1. Richards MA. The size of the prize for earlier diagnosis of cancer in England. Br J Cancer 2009;101(Suppl 2):S125–S129. 10.1038/sj.bjc.6605402 - DOI - PMC - PubMed
    1. McPhail S, Elliss-Brookes L, Shelton J, et al. . Emergency presentation of cancer and short-term mortality. Br J Cancer 2013;109:2027–34. 10.1038/bjc.2013.569 - DOI - PMC - PubMed
    1. Cancer Research UK. Cancer diagnosis and treatment statistics. 2016. http://www.cancerresearchuk.org/health-professional/cancer-statistics/di... (accessed 13 July 2016).
    1. Abdel-Rahman M, Stockton D, Rachet B, et al. . What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable? Br J Cancer 2009;101(Suppl 2):S115–S124. 10.1038/sj.bjc.6605401 - DOI - PMC - PubMed

Publication types

LinkOut - more resources